Home
Conditions
Muscle-Invasive Bladder Carcinoma

Clinical trial condition

Muscle-Invasive Bladder Carcinoma

Explore clinical trials studying Muscle-Invasive Bladder Carcinoma. Study availability and eligibility vary by location and protocol.

31 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Muscle-Invasive Bladder Carcinoma trial results

Recruiting

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

NCT06417190

Conditions: Muscle-Invasive Bladder Carcinoma, Neoplasms, Tumor
Locations: Cedars Sinai Medical Center Los Angeles, California, United States

View Trial Details

Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +137 more
Locations: Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

Alaska Oncology and Hematology LLC Anchorage, Alaska, United States

View all 744 locations

View Trial Details

Recruiting

Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer

NCT05833867

Conditions: Localized Muscle Invasive Bladder Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Recruiting

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

NCT06529822

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
Locations: AdventHealth Orlando, Florida, United States

Washington University School of Medicine St Louis, Missouri, United States

Ohio State University Columbus, Ohio, United States

View Trial Details

Recruiting

Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer

NCT06470282

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Recruiting

Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy

NCT07234968

Conditions: Bladder Cancer, Bladder Neoplasm, Bladder Transitional Cell Carcinoma, +20 more
Locations: Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States

Jefferson Einstein Philadelphia Hospital Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study

NCT07339761

Conditions: Bladder Cancer, Carcinoma, Female Urogenital Diseases, +15 more
Locations: Department of Urology, Aarhus University Hospital Aarhus, Denmark

View Trial Details

Recruiting

Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers

NCT06537960

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations: Hopital Foch Suresnes, Île-de-France Region, France

View Trial Details

Recruiting

Prophylactic Antibiotics in Cystectomy With Diversion

NCT06190197

Conditions: Ileal Conduit, Muscle-Invasive Bladder Carcinoma, Neobladder Diversion, +1 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Recruiting

Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)

NCT06571708

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations: Columbia University Irving Medical Center/ New York Presbyterian Hospital New York, United States

View Trial Details

Muscle-Invasive Bladder Carcinoma

Muscle-Invasive Bladder Carcinoma trial results

Related conditions